(ArCH), 128.5 (ArCH), 138.3 (ArCipso), 144.2 (ArCipso), 144.5
crystalline solid after recrystallisation from petrol (bp 60–
(ArCipso), 155.2 (C᎐O); m/z (APCI) 500 (4%), 448 (15), 412 (3,
80 ЊC)–ethyl acetate (0.283 g, 73%), mp >220 ЊC; [α]D25 = ϩ288.4
(c 0.5 in CHCl3) (Found: C, 75.8; H, 5.95; N, 5.5. C16H15NO2
requires C, 75.9; H, 6.0; N, 5.5%); νmax(KBr)/cmϪ1 3264, 1744,
1723; δH(400 MHz) 1.01 (3 H, d, J 6.5, 4-Me), 4.68 (1 H, q,
J 6.5, 4-H1), 5.32 (1 H, br, NH), 7.26–7.42 (8 H, m, ArCH),
7.51 (2 H, m, ArCH); δC(100 MHz) 19.3 (4-Me), 56.2 (4-C),
89.4 (5-C), 126.0 (ArCH), 126.2 (ArCH), 127.8 (ArCH), 128.1
(ArCH), 128.3 (ArCH), 128.5 (ArCH), 139.2 (ArCipso), 142.4
(ArCipso), 157.9 (2-C); m/z (APCIϩ) 254 (42%, MHϩ), 210 (100),
104 (32).
᎐
Mϩ ϩ Na), 345 (56), 316 (13), 272 (100, Mϩ Ϫ C5H11NO2).
(2R)-N-Boc-2-amino-1,1-diphenyl-3-methylbutanol 13h. The
desired amino alcohol 13h was obtained from N-Boc--valine
methyl ester 9 (R = i-Pr) (4.00 g, 0.017 mol) using the above
method, followed by recrystallisation from petrol (bp 40–
60 ЊC)–ethyl acetate as a crystalline solid (4.48 g, 74%), mp 188–
190 ЊC; [α]D25 = ϩ68.8 (c 1 in CHCl3) (Found: C, 74.3; H, 8.1; N,
3.8. C22H29NO3 requires C, 74.3; H, 8.2; N, 3.9%); νmax(film)/
cmϪ1 3428, 1680; δH(400 MHz) 0.89 (3 H, d, J 6.9, CH3), 0.91
(3 H, d, J 6.9, CH3), 1.34 [9 H, s, (CH3)3C], 1.81 (1 H, dsept,
J 2.0 and 6.9, 3-H1), 2.67 (1 H, br, OH), 4.61 (1 H, dd, J 10.2
and 2.0, 2-H1), 5.04 (1 H, d, J 10.2, NH), 7.15–7.35 (6 H, m,
ArCH), 7.46 (2 H, d, J 7.4, ArCH), 7.51 (2 H, d, J 7.7, ArCH);
δC(100 MHz) 17.4 (CH3), 22.7 (CH3), 28.7 [(CH3)3C], 28.8
(3-C), 59.0 (2-C), 79.0 [(CH3)3C], 82.4 (1-C), 125.3 (ArCH),
125.7 (ArCH), 126.7 (ArCH), 128.2 (ArCH), 128.3 (ArCH),
(4R)-5,5-Dimethyl-4-phenyloxazolidin-2-one 6e. The desired
SuperQuat 6e was obtained from the phenylglycine amino
alcohol 13e (93.8 g, 0.345 mol) by the above method as a
crystalline solid after recrystallisation from ethyl acetate–petrol
(bp 40–60 ЊC) (55.16 g, 84%), mp 149 ЊC; [α]D25 = Ϫ77.6 (c 0.5 in
CHCl3) (Found: C, 69.3; H, 7.05; N, 7.4. C11H13NO2 requires C,
69.1; H, 6.85; N, 7.3%); νmax(CHCl3)/cmϪ1 1753; δH(200 MHz)
0.93 (3 H, s, 5-Me), 1.61 (3 H, s, 5-Me), 4.66 (1 H, s, 4-H1),
6.25 (1 H, s, NH), 7.44–7.25 (5H, m, ArCH); δC(125 MHz)
23.5 (5-Me), 28.0 (5-Me), 65.9 (4-C), 84.6 (5-C), 126.7
(ArCH), 128.72 (ArCH), 128.9 (ArCH), 137.2 (ArCipso),
159.8 (2-C); m/z (CIϩ) 210 (5%), 209 (48), 193 (12), 192 (100,
MHϩ), 148 (10).
145.6 (ArCipso), 146.3 (ArCipso), 156.3 (C᎐O); m/z (APCI) 311
᎐
(5%), 282 (12, Mϩ Ϫ C4H9O), 256 (15, Mϩ Ϫ C5H7O2), 239 (22),
238 (100, Mϩ Ϫ C5H9O3), 221 (18), 196 (6), 150 (42).
General procedure for the preparation of the oxazolidinones
Potassium tert-butoxide (1.1 equiv.) was added in one portion
to a stirred solution of the N-Boc amino alcohol (1 equiv.) in
freshly distilled THF (5 cm3 mmolϪ1) at 0 ЊC. After 30 min,
the solvent was evaporated, and the residue taken up in ethyl
acetate and washed with brine. The organic layer was dried
(MgSO4) and evaporated to give crude product which was
recrystallised to yield the desired oxazolidin-2-one.
(4R)-4,5,5-Triphenyloxazolidin-2-one 6f. The desired Super-
Quat 6f was obtained from the phenylglycine derived amino
alcohol 13f (0.250 g, 0.642 mmol) by the above method as a
white solid after recrystallisation from petrol (bp 60–80 ЊC)–
ethyl acetate (0.164 g, 81%), mp >230 ЊC (lit.,19 246.5–247.2 ЊC);
[α]D25 = ϩ218.1 (c 1 in CHCl3) [lit.,19 ϩ218.15 (c 1 in CHCl3)];
νmax(KBr)/cmϪ1 3274, 1755, 1727; δH(400 MHz) 5.51 (1 H, br,
NH), 5.67 (1 H, s, 4-H1), 7.08 (5 H, s, ArCH), 7.12–7.14 (2 H,
m, ArCH), 7.18–7.21 (3 H, ArCH), 7.42 (1 H, t, J 7.5, ArCH),
7.49 (2 H, t, J 7.5, ArCH), 7.73 (2 H, d, J 7.5, ArCH); δC(100
MHz) 65.8 (4-C), 90.7 (5-C), 126.2 (ArCH), 126.5 (ArCH),
127.3 (ArCH), 127.5 (ArCH), 127.8 (ArCH), 128.3 (ArCH),
128.5 (ArCH), 128.6 (ArCH), 137.1 (ArCipso), 138.8 (ArCipso),
142.8 (ArCipso), 157.9 (2-C); m/z (APCIϩ) 374 (11%), 327 (4),
316 (4, MHϩ), 273 (18), 272 (100, MHϩ Ϫ CO2), 270 (28).
5,5-Dimethyloxazolidin-2-one 6a. The glycine derived amino
alcohol 13a (5.00 g, 26.4 mmol) was cyclised by the described
procedure and recrystallised from ethyl acetate–petrol (bp 60–
80 ЊC) to give the dimethylglycine SuperQuat 6a (2.15 g, 71%)
as off white crystals, mp 78–82 ЊC (lit.,17 79–82 ЊC); νmax(film)/
cmϪ1 3265, 1763; δH(200 MHz) 1.49 (6 H, s, 2 × 5-Me), 3.38
(2 H, s, 4-H2), 5.90 (1 H, br, NH); δC(50 MHz) 27.1 (2 × 5-Me),
52.7 (4-C), 81.1 (5-C), 160.4 (2-C); m/z (APCI) 231 (5%, M2Hϩ),
138 (6, Mϩ ϩ Na), 122 (5, Mϩ ϩ Li), 117 (8), 116 (100, MHϩ).
(4R)-5,5-Dimethyl-4-isopropyloxazolidin-2-one
6g.
The
5,5-Diphenyloxazolidin-2-one 6b. The glycine derived amino
alcohol 13b (2.00 g, 6.38 mol) was cyclised by the described
procedure and recrystallised from hot ethyl acetate to give the
diphenylglycine SuperQuat 6b (1.10 g, 72%), mp 196–197 ЊC
(Found: C, 75.30; H, 5.3; N, 5.8. C15H13NO2 requires C, 75.30;
H, 5.5; N, 5.9%); νmax(KBr)/cmϪ1 3260, 1740; δH(400 MHz) 4.21
(2 H, s, 4-H2), 5.96 (1 H, br, NH), 7.29–7.43 (10 H, m, ArCH);
δC(50 MHz) 53.4 (4-C), 86.5 (5-C), 125.5 (ArCH), 128.2
(ArCH), 128.6 (ArCH), 142.4 (ArCipso), 158.8 (2-C); m/z
(APCI) 251 (5%), 241 (6), 240 (MHϩ, 52), 197 (25), 196 (100,
MHϩ Ϫ CO2).
desired SuperQuat 6g was obtained from the valine derived
amino alcohol 13g (3.04 g, 0.013 mol) by the above method as
white needles after recrystallisation from petrol (bp 40–60 ЊC)–
ethyl acetate (1.46 g, 72%), mp 87 ЊC; [α]D25 = Ϫ24.2 (c 1 in
CHCl3) (Found: C, 61.3; H, 9.6; N, 8.80. C8H15NO2 requires
C, 61.1; H, 9.6; N, 8.9%); νmax(KBr)/cmϪ1 3247, 1739; δH(400
MHz) 0.92 [3 H, d, J 6.6, (CH3)2CH], 0.99 [3 H, d, J 6.6,
(CH3)2CH], 1.39 (3 H, s, 5-Me), 1.49 (3 H, s, 5-Me), 1.82 [1 H,
dsept, J 8.6 and 6.6, CH(CH3)2], 3.19 (1 H, d, J 8.6, 4-H1), 6.31
(1 H, br, NH); δC(50 MHz) 19.8 (CH3), 21.1 (CH3), 21.1 (CH3),
28.3 (CH3), 28.5 [(CH3)2CH], 68.5 (4-C), 83.9 (5-C), 159.9
(2-C); m/z (APCIϩ) 315 (4%, M2Hϩ), 180 (4), 159 (11), 158 (100,
MHϩ).
(4R)-4,5,5-Trimethyloxazolidin-2-one 6c. The desired Super-
Quat 6c was obtained from the alanine derived amino alcohol
13c (2.431 g, 12.0 mmol) by the above method as a white
crystalline solid after recrystallisation from petrol (bp 60–
(4R)-5,5-Diphenyl-4-isopropyloxazolidin-2-one
6h.
The
80 ЊC)–ether (1.015 g, 66%), mp 64 ЊC (lit.,18 61 ЊC); [α]D25
=
desired SuperQuat 6h was obtained from the valine derived
amino alcohol 13h (3.043 g, 8.56 mmol) by the above method as
white needles after recrystallisation from ethyl acetate (1.785 g,
74%), mp >220 ЊC (lit.,19 252.9–253.5 ЊC); [α]D25 = ϩ315.6 (c 0.5
in CHCl3) [lit.,19 ϩ270.78 (c 1 in CHCl3)]; νmax(KBr)/cmϪ1 3293,
1766, 1745; δH(200 MHz) 0.69 (3 H, d, J 6.8, CH3CH), 0.90
(3 H, d, J 6.8, CH3CH), 1.85 [1 H, dsept, J 3.5 and 6.8,
(CH3)2CH], 4.36 (1 H, d, J 3.5, 4-H1), 6.32 (1 H, br, NH),
7.25–7.43 (8 H, m, ArCH), 7.55 (2 H, dd, J 6.6 and 1.0, ArCH);
δC(100 MHz) 18.3 (CH3), 23.5 (CH3), 32.3 [(CH3)2CH], 68.5
(4-C), 92.1 (5-C), 128.4 (ArCH), 129.00 (ArCH), 130.4
(ArCH), 130.8 (ArCH), 131.3 (ArCH), 141.8 (ArCipso), 146.6
Ϫ2.85 (c 4 in CHCl3) [lit.,18 Ϫ2.6 (c 4 in CHCl3)]; νmax(KBr)/
cmϪ1 3274, 1733; δH(400 MHz) 1.15 (3 H, d, J 6.5, 4-Me), 1.30
(3 H, s, 5-Me), 1.42 (3 H, s, 5-Me), 3.62 (1 H, q, J 6.5, 4-H1),
6.45 (1 H, br, NH); δC(100 MHz) 16.1 (CH3), 21.4 (CH3), 27.1
(CH3), 57.1 (4-C), 83.5 (5-C), 159.2 (2-C); m/z (APCI) 281 (5%,
M2ϩ ϩ Na), 259 (8, M2ϩ ϩ H), 210 (6), 152 (33, Mϩ ϩ Na), 130
(100, MHϩ).
(4R)-5,5-Diphenyl-4-methyloxazolidin-2-one 6d. The desired
SuperQuat 6d was obtained from the alanine derived amino
alcohol 13d (0.500 g, 1.53 mmol) by the above method as a
J. Chem. Soc., Perkin Trans. 1, 1999, 387–398
393